A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, doctors, or other sources.

Omitting pelvic lymphadenectomy may be beneficial for patients with early-stage cervical cancer undergoing sentinel lymph node biopsy and radical hysterectomy.

(HealthDay News) — Circulating tumor DNA (ctDNA) can be detected more than 3 years prior to a clinical cancer diagnosis, according to a research brief published in Cancer Discovery.

(HealthDay News) — More than 460 employees who were laid off from their jobs at the US Centers for Disease Control and Prevention (CDC) are being rehired, the Associated Press reported last week.

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for chemotherapy in certain patients with NSCLC.

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Workers at the NIH sent a letter protesting the Trump administration’s cuts to the agency's budget, staff, and research.

The FDA has approved Zusduri (mitomycin intravesical solution) to treat adults with recurrent, low-grade, intermediate-risk NMIBC.

Keytruda (pembrolizumab) is now approved as perioperative treatment for patients with head and neck squamous cell carcinoma.

Sacituzumab govitecan plus pembrolizumab improves outcomes vs chemotherapy plus pembrolizumab in patients with previously ...

The US Food and Drug Administration (FDA) has approved a new tablet formulation of Brukinsa (zanubrutinib), which is expected to replace the current capsule formulation in October 2025. Brukinsa, a ...

The FDA has granted fast track designation to nadunolimab for use in combination with gemcitabine and nab-paclitaxel to treat patients with previously untreated, metastatic PDAC with high IL1RAP ...